Interest in the functioning of ubiquinone in mitochondrial respiration has been stimulated by the 'Q-cycle' hypothesis of Mitchell (1976) . Kroger & Klingenberg (1967 , 1973a have provided evidence that ubiquinone is mobile in the plane of the membrane and serves as a redox pool linking dehydrogenases with cytochrome chains. Thus, there was no requirement for direct association of dehydrogenase molecules with cytochrome chains; the segments of the respiratory chain occurred independently in the same membrane and were linked by the mobile hydrogen carrier, ubiquinone. The 'pool function' of the ubiquinone is essentially an extension of Green's original postulate that ubiquinone functions as a 'mobile carrier' (Green, 1962) . The 'Q-cycle' hypothesis proposed, among other things, that ubiquinone is co-ordinately reduced by electrons from both the dehydrogenase and the cytochrome b-c1 segment of the electron-transport sequence at a site on one side of the membrane. It is possible therefore that the association of dehydrogenases and cytochromes may be closer than is suggested by the work of Kroger & Klingenberg (1973a,b) . Several other lines of evidence support this idea. Firstly, a succinate-cytochrome c oxidoreductase complex has been described that may be reversibly resolved into soluble succinate dehydrogenase and a cytochrome segment by alkaline treatment (Yu et al., 1974) . Thus it seems likely that the association of succinate * To whom correspondence should be addressed. Vol. 174 dehydrogenase with the cytochromes is in part determined by protein-protein interactions.
Secondly, NADH-ubiquinone oxidoreductase and ubiquinol-cytochrome c oxidoreductase (Complexes I and III respectively) apparently interact in a 1:1 molar ratio to give NADH-cytochrome c oxidoreductase (Complex I-Complex IIl) that contains equimolar FMN and cytochrome cl (Hatefi et al., 1962a; Fowler & Richardson, 1963) . Furthermore, NADH-cytochrome c oxidoreductase, like succinatecytochrome c oxidoreductase, may be isolated as a single entity by detergent and salt fractionation of mitochondria (Hatefi et al., 1961) .
We decided to investigate the interaction between NADH dehydrogenase and the cytochromes by using the purified lipoprotein Complexes I and III (Hatefi et al., 1962b,c) . In previous papers we showed that the phospholipid of Complex I is essential for rotenone-sensitive ubiquinone-I reduction (Heron et al., 1977) . Although phospholipids are required for the correct functioning of the enzyme protein, effects of freezing of the lipid on enzyme activity are caused by lowering of the concentration and mobility of ubiquinone in the lipid phase (Ragan, 1978) . We have now extended these observations to the interaction of Complexes I and III. In the present paper we provide evidence that these complexes associate in a 1: 1 molar ratio to give a Complex I-Complex III unit. The ubiquinone associated with this unit does not equilibrate rapidly with other such units, or free Complex I and Complex lII. In the following paper (Heron et al., 1978) , restoration of the 'Q-pool' function to this system will be described.
Materials and Methods Enzyme preparations
Complex I (EC 1.6.99.3) and Complex III were prepared from bovine heart mitochondria as described by Hatefi & Rieske (1967b) and Rieske (1967a) Ragan & Racker (1973) . Assays NADH-ubiquinone-1 oxidoreductase activity was measured as previously described (Ragan, 1976) . NADH-cytochrome c oxidoreductase was measured essentially as described by Hatefi & Rieske (1967a) , except that the phospholipid supplement was either omitted or replaced by soya-bean phosphatidylcholine (0.4mM as phosphorus) (Ragan, 1976) . The oxidation of 6-decyl-2,3-dimethoxy-5-methyl-1,4-benzoquinol by cytochrome c was measured exactly as for NADH-cytochrome c oxidoreductase, except that 40M-benzoquinol replaced the NADH, and phospholipid was omitted. All rates were corrected for non-enzymic reduction of cytochrome c. Acid-extractable FMN was assayed as described by Ragan (1976) . Ubiquinone-10 was extracted and assayed by the method of Kroger & Klingenberg (1966) . Cytochrome cl was determined essentially as described by Rieske (1967b) . Protein was measured by the method of Lowry et al. (1951) , with bovine serum albumin (fraction V from Sigma) as a standard.
Determination ofactivation energies
Activation energies were obtained from measurements of activity as a function of temperature. Hatefi et al. (1962a) , Complex I-Complex III is formed after mixing the two Complexes as concentrated solutions, and diluting out the detergent. In the experiments described in the present paper, solutions of Complexes I and III (containing at least 10mg of protein/ml) were mixed and diluted with 0.67M-sucrose/50mM-Tris/HCI, pH8, at 0°C until the Complex I concentration was less than 0.5mg of protein/ml. The diluted samples were incubated at 0°C for at least 30min to allow full association (Fowler & Richardson, 1963 (Rieske, 1976; Ragan, 1976) . Complex I preparations always contained some Complex III (Hatefi et al., 1962a) . Estimates of the extent of this contamination on the basis of either the cytochrome cl content or the 6-decyl-2,3-dimethoxy-5 -methyl-1,4-benzoquinolcytochrome c oxidoreductase activity of the Complex I gave identical results. In the preparation used in Fig. 1 (Hatefi et al., 1962a; Fowler & Richardson, 1963) . The curve of Fig. 1 and diluted to a final volume of 800/il with 0.67M-sucrose/50 mM-Tris/HCl, pH 8.0, at 4°C. After incubation for 1 h on ice, samples were assayed for NADHcytochrome c oxidoreductase activity at 30°C in the absence of a phospholipid supplement to the assay. The curve was drawn according to the analysis of Table I by using a value for b/(c x d) averaged from the first six lines of Table 1 , i.e. 7.36. curve of Fig. 1 and the apparent stoicheiometry were unchanged.
The turnover number of Complex III is the same whether the enzyme is in isolation or in Complex IComplex III and is considerably greater than that of Complex I. Therefore the apparent 1 :1 molar stoicheiometry cannot be explained on a kinetic basis. This point is considered in greater detail in the following paper (Heron et al., 1978) . Thus Fig. 1 of Complex I. This behaviour is reminiscent of that of the covalent modifier diphenyleneiodonium (Ragan & Bloxham, 1977) , which shows a similar relationship between inhibition and the extent of incorporation of the inhibitor. Titration of mixtures of Complex I and Complex III with antimycin produced similar results to those of Fig. 2 . Thus in Fig. 3 (Fowler & Richardson, 1963 Fig. 3 shows that, if antimycin redistribution had occurred, some 70 % restoration of activity would have been expected. We have repeated this experiment under somewhat different conditions, which enable a clearer distinction to be made between the two possible explanations. In the experiment of Fig. 4 (Kroger & Klingenberg, 1973b Rieske (1976) . However, at 3°C the reduction was clearly biphasic. The relative extents of the slow and fast phases depended on the molar ratio of Complex I to Complex III (Fig. 5, inset) . The fast phase showed saturation with increasing Complex Ill concentration and the curve was very similar to that of Fig. 1 Ragan, 1978) . The activation energy for the oxidation of 6-decyl-2,3-dimethoxy-5-methyl-1,4-benzoquinol by cytochrome c was approx. 4OkJ/mol, whether measured with Complex III alone or in after addition of O.1,pmol of NADH, and at either 25 or 3°C. Curves (a)-(f) were obtained at 3°C, and curve (g) at 25°C. Molar ratios of Complex III to Complex1were:(a)0.l;(b)0.6;(c) 1.1;(d)1.6;(e)2.l; (f) 2.6; (g) 2.6. The inset shows the extent of fast (e) and fast-plus-slow phases (A) at 3°C, and total extents at 25°C (U) respectively. This suggests that the oxidoreduction of endogenous ubiquinone-10 proceeds somewhat differently from the oxidation and, particularly, the reduction of exogenous quinones. We do not feel that the lower activation energy for ubiquinone-10 oxidoreduction can be attributed to the different chemical nature of the exogenous quinones, since we have obtained an activation energy of 8OkJ/mol for the reduction of 6-decyl-2,3-dimethoxy-5-methoxy-1,4-benzoquinone, which differs greatly from ubiquinone-1 in hydrophobicity (Ragan, 1978) . We propose that the lower activation energy for endogenous ubiquinone-10 reduction may be due to the environment in which the quinone is situated. Orientation of the site of reduction of ubiquinone-10 with respect to the site of oxidation might cause a lowering of the activation energy to that observed for the overall process.
The ubiquinone-10 content of the Complex I and Complex III used in these experiments was 2.2 and 2.6pmol/min per mg of protein respectively. Thus in an equimolar mixture of Complex I and Complex III there were 2.8mol of ubiquinone-10 per mol of Complex I or III. This concentration is sufficient for nearly maximal rates of electron transport, as shown in the following paper (Heron et al., 1978) . It is reasonable that concentrations of this order of magnitude might be specifically associated with one or both Complexes and might have quite limited mobility within the interface between the Complexes. Such limited mobility is also supported by the structure of ubiquinone as revealed in molecular models (Trumpower & Landeen, 1977) .
We have also found that the phospholipids of Complex I-Complex III can be substituted by 1,2-ditetradecanoyl -sn -glycero -3 -phosphocholine with (Ragan, 1978 (Heron et al., 1978) it is shown that under certain circumstances (e.g. Fig. 3 (Ragan, 1978) it was shown that the rate of reduction of ubiquinone analogues by Complex I depended only on the amount of the quinone in the lipid phase, regardless of whether the lipid was only annular (Warren et al., 1975) or consisted of a large bulk phase. Thus movement of quinone molecules between water, bulk and annular-lipid phases was never rate-limiting (except when the bulk lipid was frozen). This does not appear to be the case for Complex 1-Complex III. Thus the interaction of the complexes imposes a restriction on the diffusion of ubiquinone-10 between the protein and its associated annular lipid, and any other protein and lipid.
We suggest that the association of Complex I with Complex III is determined to a considerable extent by protein-protein interactions. Ubiquinone-l0 is effectively trapped between the component complexes in an environment that may be partly protein and partly derived from the annuli of those complexes. This environment promotes oxidoreduction of the ubiquinone-10 by lowering the activation energy of ubiquinone reduction.
The amount of ubiquinone-10 trapped in this environment appears to be less than 3 molecules per molecule of Complex I-Complex III, and this concentration is sufficient for near maximum rates of electron transport to cytochrome c [see the following paper, Heron et al. (1978) ]. These results are consistent with the evidence for an oriented pair of ubiquinone molecules in the respiratory chain of intact mitochondria (Salerno et al., 1977) . Stabilization of the semiquinones formed from this pair of molecules was ascribed to a ubiquinone-binding protein, whose existence has been postulated by Yu et al. (1977) . The present results are fully consistent with the involvement of such proteins in the Complex I-Complex Ill interaction. We have shown that ubiquinone mobility is restricted. However, ubiquinone may equally well be totally immobilized by binding to protein. As yet there is no direct evidence for such specific proteins, and it is possible that phospholipids may be important in ubiquinone binding. In particular, Heron et al. (1977) have shown an essential requirement for cardiolipin in NADHubiquinone-l oxidoreductase activity. This observation and the presence of cardiolipin almost exclusively in mitochondria still require explanation.
The extensive investigations by Kroger & Klingenberg (1973a,b) of the kinetic and steady-state behaviour of ubiquinone in submitochondrial particles have shown that ubiquinone behaves as a single homogeneous pool whose redox state is determined by the relative activities of the donor to and acceptor from this pool. They propose that, as well as acting as a 'serial' mediator of electron transfer from dehydrogenases to cytochromes, ubiquinone must also act as 'lateral' mediator between the cytochrome chains, i.e. a molecule of ubiquinone can be reduced by any dehydrogenase and oxidized by any cytochrome chain. It is clear that this behaviour does not hold for the system described here. In the following paper (Heron et al., 1978) , restoration of theoretical 'Q-pool' behaviour to the Complex I-Complex III system will be described. This can be achieved by increasing the ubiquinone-10 and phospholipid concentrations to values more closely approaching those found in mitochondrial membranes. The demonstration that the Complex I-Complex III system can be made to operate exactly as in the natural membrane provides strong evidence that the conclusions ofthis paper do not relate to an artifact produced in vitro. The relationship between the system described here and the behaviour in vivo is discussed at greater length in the following paper (Heron et al., 1978) .
